A feline model of Niemann-Pick disease type C (NPC) was employed to evaluat
e the effect of dietary cholesterol restriction on progression of disease.
Two NPC-affected treated cats were fed a cholesterol-restricted diet beginn
ing at 8 weeks of age; the cats remained on the diet for 150 and 270 days r
espectively. The study goal was to lower the amount of low density lipoprot
ein (LDL) available to cells, hypothetically reducing subsequent lysosomal
accumulation of unesterified cholesterol and other lipids. Neurological pro
gression of disease was not altered and dietary cholesterol restriction did
not significantly decrease storage in NPC-affected treated cats. One NPC-a
ffected treated cat had decreased serum alkaline phosphatase activity (ALP)
and decreased serum cholesterol concentration. Liver lipid concentrations
of unesterified cholesterol, cholesterol ester and phospholipids in NPC-aff
ected treated cats were similar to those seen in NPC-affected untreated cat
s. Ganglioside concentrations in the NPC-affected treated cats and NPC-affe
cted untreated cats were similar. Histological findings in liver sections f
rom NPC-affected treated cats showed a diffuse uniform microvacuolar patter
n within hepatocytes and Kupffer cells, in contrast to a heterogeneous macr
o/microvacuolar pattern and prominent nodular fibrosis in NPC-affected untr
eated cats. Similar differences in vacuolar patterns were seen in splenic m
acrophages. Although some hepatic parameters were modified, dietary cholest
erol restriction did not appear to alter disease progression in NPC-affecte
d kittens.